However, in this study, all tumor samples showed cytoplasmic or both cytoplasmic and nuclear FOXP3 expression, suggesting frequent deregulation of FOXP3 localization and failure to translocate to the nucleus in breast cancer cells and explaining the correlation with worse prognosis. The gene discussed is FOXP3; the disease is neoplasm.